Sequential Use of Targeted Therapies (TT) in Metastatic Renal Cell Cancer (mRCC): Overall Results of a Large Experience

Схожие документы

• Analysis of the effect of clinical and laboratory parameters on survival in patients with metastatic renal cell cancer with intermediate prognosis according to IMDC (International mRCC Database Consortium)
  по: D. V. Semenov, и др.
  Опубликовано: (2023-07-01)
• Nivolumab versus Cabozantinib: Comparing Overall Survival in Metastatic Renal Cell Carcinoma.
  по: Witold Wiecek, и др.
  Опубликовано: (2016-01-01)
• Photodynamic therapy: development of methods and clinical applications in FCI MRCC MOH
  по: M. A. Kaplan, и др.
  Опубликовано: (2014-03-01)
• Effects of targeted therapy for RCC on LUTS in elderly male patients
  по: Li Xiaona, и др.
  Опубликовано: (2025-12-01)
• Subcarrier synchronization for satellite USB TT&C
  по: Zhang Shiwei, и др.
  Опубликовано: (2022-05-01)